AKTUALNIE REKRUTUJĄCE BADANIA
Badania prowadzone są w ośrodkach badań klinicznych PRATIA
Chłoniak grudkowy FL
NAZWA BADANIA
OPIS BADANIA
OŚRODKI PROWADZĄCE
NAZWA BADANIA
OPIS BADANIA
Study of Tazemetostat Versus Placebo When Given in Combination With Lenalidomide and Rituximab in Participants With Relapsed/Refractory Follicular Lymphoma (SYMPHONY-1)
NAZWA BADANIA
OPIS BADANIA
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma (EPCORE FL-1)
NAZWA BADANIA
OPIS BADANIA
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NAZWA BADANIA
OPIS BADANIA
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. (InMIND)
NAZWA BADANIA
OPIS BADANIA
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma (EPCORE™ NHL-1)
W tym obszarze czytaj więcej:
Menu
